Trivascular Technologies Inc (TRIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2012 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 32,896 | 38,108 | 45,393 |
| Marketable Securities | 46,084 | N/A | N/A |
| Receivables | 6,565 | 4,741 | 1,730 |
| Inventories | 8,570 | 7,042 | 8,062 |
| TOTAL | $97,047 | $52,326 | $56,333 |
| Non-Current Assets | |||
| PPE Net | 1,248 | 1,505 | 2,286 |
| Intangibles | 9,441 | 9,441 | 9,477 |
| Other Non-Current Assets | 797 | 1,428 | 898 |
| TOTAL | $11,486 | $12,374 | $12,661 |
| Total Assets | $108,533 | $64,700 | $68,994 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 1,862 | 1,678 | 1,130 |
| Accrued Expenses | 8,465 | 6,129 | 3,225 |
| TOTAL | $10,327 | $7,807 | $4,355 |
| Non-Current Liabilities | |||
| Long Term Debt | 55,004 | 44,288 | 42,765 |
| Other Non-Current Liabilities | 3,629 | 1,413 | 1,598 |
| TOTAL | $58,633 | $45,701 | $44,363 |
| Total Liabilities | $68,960 | $53,508 | $48,718 |
| Shareholders' Equity | |||
| Shares Outstanding, K | 20,384 | N/A | N/A |
| Common Shares | 202 | 6 | 6 |
| Retained earnings | -295,894 | -238,521 | -188,213 |
| Other shareholders' equity | -180 | 240,156 | 200,163 |
| TOTAL | $39,573 | $11,192 | $20,276 |
| Total Liabilities And Equity | $108,533 | $64,700 | $68,994 |